KALY - Kali-Extracts Announces $100,000 Order of its Hemp4mula CBD Infused Chewing Gum Available Soon on USMJ E-commerce Site

Dallas, TX -- December 17, 2018 -- InvestorsHub NewsWire -- Kali-Extracts, Inc. (Kali, Inc. dba/Kali-Extracts, Inc.) (USOTC: KALY) (“KALY”) today announced a $100,000 wholesale order of its Hemp4mula CBD Infused Chewing Gum. The wholesale buyer plans to have Hemp4mula CBD Infused Chewing Gum available for sale at select retail drugstore locations and through the soon to be launched USMJ E-commerce Site from North American Cannabis Holdings, Inc. (USOTC: USMJ).

Earlier this month, Kali-Extracts announced launching its own line of hemp-derived CBD infused candies and vapes under the brand name Hemp4mula. Kali-Extracts Hemp4mula CBD Infused Chewing Gum will come in a blister back of 8 pieces with 10 mg each of hemp-derived CBD. Kali-Extracts expects to soon produce hemp-derived CBD infused mints and gummies. Hemp4mula vapes are anticipated to be in production early next year.

KALY recently acquired a biotech company with a patented cannabis extraction process. Accordingly, KALY updated its overall business plan (a presentation on the company’s updated business plan is available on KALY’s website). Hemp4mula is part of the updated business plan which management is rapidly executing. The company recently announced a $300,000 hemp-derived CBD extraction contract with Puration, Inc. (USOTC: PURA). The CBD Kali-extracts will produce is to support PURA’s contract to produce a private labeled CBD infused Water for Generex Biotechnology, (OTCQB: GNBT).

To learn more about the company visit https://www.kali-extracts.com/

Check back frequently to the company’s website and to the OTCMarkets website for more updates coming soon as management populates the new company website with additional information and brings all corporate information current on the OTCMarkets website.

This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), and as such, may involve risks and uncertainties. These forward looking statements relate to, amongst other things, current expectation of the business environment in which the company operates, potential future performance, projections of future performance and the perceived opportunities in the market. The company's actual performance, results and achievements may differ materially from the expressed or implied in such forward-looking statements as a result of a wide range of factors.

CONTACT:
Frederick Ferri
ir@kali-extracts.com
(214) 210-0459